glp 1 and ovarian cancer GLP-1 receptor agonists risk in adults with obesity: A new chapter in metabolic oncology? glp 1 ovarian cancer Association

The 50 neonates who subsequently developed T1D were matched with 200 controls, 4 for each of the index cases and born +/ 1 day

GLP-1 use among US adolescents surges, but long-term health effects remain unknown GLP-1 use among US teenagers and young adults in obesity care jumped from 88.2% to 96.1% between 2022 and 2026, while the use of bariatric surgery declined

But consider the cost of: Ongoing health conditions related to excess weight Medications for blood pressure, cholesterol, or diabetes Lost productivity and quality of life Previous diet programs that didnt work For many patients, Semaglutide pays for itself in reduced healthcare costs and improved wellbeing

Before April, the city was bracing for a worst-case scenario